slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
89,6 BDT | 0,00% |
|
-1,43% | +6,16% |
Vakgebied
Aantal werknemers: 4 143
Verkoop per activiteit
BDT in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Human Health
80,9
%
| 4 553 | 81,6 % | 5 388 | 80,9 % | +18,36% |
Veterinary
19,1
%
| 1 030 | 18,4 % | 1 270 | 19,1 % | +23,30% |
Verkoop per regio
BDT in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Bangladesh
100,0
%
| 4 759 | 100,0 % | 5 706 | 100,0 % | +19,91% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mohammad Shafiq
CEO | Chief Executive Officer | 63 | 25-11-20 |
Director of Finance/CFO | 42 | 25-03-13 | |
Director of Finance/CFO | 54 | 25-11-20 | |
Chief Administrative Officer | 44 | 07-04-13 | |
Malay Kumar Dey
CTO | Chief Tech/Sci/R&D Officer | 39 | 15-11-20 |
Shamim Rabbani
COO | Chief Operating Officer | 64 | 01-10-20 |
Sayeed Ahmed
BRD | Director/Board Member | 46 | 25-11-20 |
Sanjoy Banik
PRN | Corporate Officer/Principal | 49 | 01-07-14 |
Corporate Officer/Principal | 56 | 04-10-20 | |
Corporate Officer/Principal | 44 | 04-10-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 51 | 12-02-20 | |
Mohammad Shafiq
CEO | Chief Executive Officer | 63 | 25-11-20 |
Director/Board Member | 44 | 25-11-20 | |
Director of Finance/CFO | 54 | 25-11-20 | |
Sayeed Ahmed
BRD | Director/Board Member | 46 | 25-11-20 |
Zahara Rasul
BRD | Director/Board Member | 50 | 25-11-20 |
Tarana Ahmed
BRD | Director/Board Member | 45 | 25-11-20 |
Masuma Parvin
BRD | Director/Board Member | 56 | 25-12-20 |
Director/Board Member | 57 | 06-09-21 | |
Director/Board Member | 51 | 28-11-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 107 416 217 | 106 342 055 ( 99,00 %) | 0 | 99,00 % |
Bedrijfsgegevens
![Adres Navana Pharmaceuticals PLC(NAVANAPHAR)](https://cdn.zonebourse.com/static/address/145512643.png)
Sector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
+6,16% | 81,91 mln. | |
+55,32% | 815 mld. | |
-6,75% | 352 mld. | |
+13,56% | 314 mld. | |
+10,68% | 303 mld. | |
+16,57% | 242 mld. | |
+2,04% | 224 mld. | |
+13,31% | 218 mld. | |
+8,48% | 168 mld. | |
-2,81% | 159 mld. |
- Beurs
- Aandelen
- Koers NAVANAPHAR
- Onderneming Navana Pharmaceuticals PLC